% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Tavakoli:163204,
author = {A. A. Tavakoli$^*$ and T. A. Kuder$^*$ and D. Tichy$^*$ and
J. P. Radtke$^*$ and M. Görtz and V. Schütz and A.
Stenzinger and M. Hohenfellner and H.-P. Schlemmer$^*$ and
D. Bonekamp$^*$},
title = {{M}easured {M}ultipoint {U}ltra-{H}igh b-{V}alue
{D}iffusion {MRI} in the {A}ssessment of {MRI}-{D}etected
{P}rostate {L}esions.},
journal = {Investigative radiology},
volume = {56},
number = {2},
issn = {0020-9996},
address = {[s.l.]},
publisher = {Ovid},
reportid = {DKFZ-2020-01901},
pages = {94-102},
year = {2021},
note = {#EA:E010#LA:E010#2021 Feb 1;56(2):94-102},
abstract = {The aim of this study was to assess quantitative ultra-high
b-value (UHB) diffusion magnetic resonance imaging
(MRI)-derived parameters in comparison to standard clinical
apparent diffusion coefficient (SD-ADC-2b-1000,
SD-ADC-2b-1500) for the prediction of clinically significant
prostate cancer, defined as Gleason Grade Group greater than
or equal to 2.Seventy-three patients who underwent 3-T
prostate MRI with diffusion-weighted imaging acquired at b =
50/500/1000/1500s/mm and b =
100/500/1000/1500/2250/3000/4000 s/mm were included.
Magnetic resonance lesions were segmented manually on
individual sequences, then matched to targeted transrectal
ultrasonography/MRI fusion biopsies. Monoexponential 2-point
and multipoint fits of standard diffusion and of UHB
diffusion were calculated with incremental b-values.
Furthermore, a kurtosis fit with parameters Dapp and Kapp
with incremental b-values was obtained. Each parameter was
examined for prediction of clinically significant prostate
cancer using bootstrapped receiver operating characteristics
and decision curve analysis. Parameter models were compared
using Vuong test.Fifty of 73 men (age, 66 years
[interquartile range, 61-72]; prostate-specific antigen, 6.6
ng/mL [interquartile range, 5-9.7]) had 64 MRI-detected
lesions. The performance of SD-ADC-2b-1000 (area under the
curve, 0.82) and SD-ADC-2b-1500 (area under the curve, 0.82)
was not statistically different (P = 0.99), with
SD-ADC-2b-1500 selected as reference. Compared with the
reference model, none of the 19 tested logistic regression
parameter models including multipoint and 2-point UHB-ADC,
Dapp, and Kapp with incremental b-values of up to 4000 s/mm
outperformed SD-ADC-2b-1500 (all P's > 0.05). Decision curve
analysis confirmed these results indicating no higher net
benefit for UHB parameters in comparison to SD-ADC-2b-1500
in the clinically important range from $3\%$ to $20\%$ of
cancer threshold probability. Net reduction analysis showed
no reduction of MR lesions requiring biopsy.Despite
evaluation of a large b-value range and inclusion of
2-point, multipoint, and kurtosis models, none of the
parameters provided better predictive performance than
standard 2-point ADC measurements using b-values 50/1000 or
50/1500. Our results suggest that most of the diagnostic
benefits available in diffusion MRI are already represented
in an ADC composed of one low and one 1000 to 1500 s/mm
b-value.},
cin = {E010 / E020 / C060},
ddc = {610},
cid = {I:(DE-He78)E010-20160331 / I:(DE-He78)E020-20160331 /
I:(DE-He78)C060-20160331},
pnm = {315 - Bildgebung und Radioonkologie (POF4-315)},
pid = {G:(DE-HGF)POF4-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:32930560},
doi = {10.1097/RLI.0000000000000712},
url = {https://inrepo02.dkfz.de/record/163204},
}